Late Lumen Loss Measurement

Known as: LATELOSS, Late Loss 
The difference between the mean minimum lumen diameter (MLD) assessed immediately after an index procedure and the MLD assessed at follow-up… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
OBJECTIVES The aim of this study was to evaluate the efficacy of drug-eluting balloons (DEB) compared with paclitaxel-eluting… (More)
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2008
Highly Cited
2008
BACKGROUND A fully bioabsorbable drug-eluting coronary stent that scaffolds the vessel wall when needed and then disappears once… (More)
Is this relevant?
Highly Cited
2006
Highly Cited
2006
BACKGROUND The use of the Endeavor stent might reduce restenosis and stent thrombosis at 9 months. METHODS AND RESULTS Patients… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
BACKGROUND Published rates of coronary restenosis have fallen below 10% in drug-eluting stent trials. Early evaluations of new… (More)
  • table 1
  • table 2
  • figure 1
  • figure 3
  • figure 2
Is this relevant?
Highly Cited
2005
Highly Cited
2005
OBJECTIVES We sought to evaluate the relationship between angiographic late loss and clinical outcomes in the drug-eluting stent… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
PURPOSE To investigate further the safety and efficacy of the sirolimus-eluting S. M.A.R.T. Nitinol Self-expanding Stent by… (More)
Is this relevant?
Review
2005
Review
2005
BACKGROUND Binary angiographic and clinical restenosis rates can vary widely between clinical studies, even for the same stent… (More)
  • figure 1
  • table 1
  • table 2
  • figure 3
  • figure 2
Is this relevant?
Highly Cited
2001
Highly Cited
2001
BACKGROUND Despite limiting elastic recoil and late vascular remodeling after angioplasty, coronary stents remain vulnerable to… (More)
  • figure 2
  • table 1
  • figure 1
  • figure 3
  • table 2
Is this relevant?
Highly Cited
1999
Highly Cited
1999
BACKGROUND Stenting likely decreases the need for target-vessel revascularization procedures in diabetic patients compared with… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Is this relevant?
Highly Cited
1993
Highly Cited
1993
Diabetes mellitus is a well-known risk factor for the development of atherosclerotic coronary artery disease [1, 2]. Findings in… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?